Product Description
Product Name: Nelfinavir Mesylate Tablets
Strength: 250 mg
Form: Oral Tablet
Category: Antiretroviral (Protease Inhibitor)
Indication: Human Immunodeficiency Virus (HIV-1) Infection
Nelfinavir Mesylate 250 mg Tablets is an antiretroviral medication used in combination with other antiretroviral agents for the treatment of HIV-1 infection. Belonging to the class of protease inhibitors, Nelfinavir helps reduce the viral load in the bloodstream, supporting immune system recovery and reducing the risk of HIV-related complications.
Mechanism of Action:
Nelfinavir inhibits the HIV-1 protease enzyme, which is essential for viral replication. By preventing the cleavage of viral polyproteins, it leads to the formation of immature, non-infectious viral particles, thereby lowering the amount of HIV in the blood.
Key Benefits:
Effective component of combination antiretroviral therapy (cART)
Helps reduce HIV viral load and increase CD4+ cell counts
Supports long-term immune function preservation
Suitable for both treatment-naïve and treatment-experienced individuals
Dosage & Administration:
The typical adult dose is 1250 mg twice daily or 750 mg three times daily, taken with food to enhance absorption. Dosage may be adjusted based on individual treatment regimens.
Important Information:
Must be used in combination with other antiretroviral drugs
Not a cure for HIV, but essential for viral suppression and disease management
Regular monitoring of viral load, liver function, and lipid profile is recommended
Caution is advised when used with CYP3A4 substrates or inhibitors, due to potential drug interactions
